Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Grant/Award of 20,000 URGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | UroGen Pharma Ltd. (URGN) | Grant/Award | 20,000 | n/a |
| Feb 4, 2026 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 929,913 | n/a |
| Sep 16, 2025 | LB PHARMACEUTICALS INC (LBRX) | Conversion | 547,648 | n/a |
| Aug 27, 2025 | UroGen Pharma Ltd. (URGN) | Grant/Award | 20,000 | n/a |
| Jan 29, 2025 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 369,957 | n/a |
| Aug 8, 2024 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Jun 26, 2024 | Kronos Bio, Inc. (KRON) | Grant/Award | 34,000 | n/a |
| Jun 14, 2024 | Ginkgo Bioworks Holdings, Inc. (DNA) | Exercise/Conversion | 105,263 | n/a |
| May 21, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 344,828 | $1.00M |
| Jan 31, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 211,973 | n/a |